Dr. Jeffrey Glenn Launches Center for Translational Research at Stanford
Dr. Glenn, an associate professor of gastroenterology, hepatology, microbiology and immunology, established the center through a $28 million, five-year grant from the National Institute of Allergy and Infectious Diseases, a part of the National Institutes of Health.
The center will focus on developing drug therapies that block resources in host cells that viruses require for replication, rather than directly targeting viruses. "The idea of the center is to change that paradigm for antiviral therapy," said Dr. Glenn in the Stanford report.
Dr. Glenn and 11 other Stanford faculty members are working at the center.
More Articles on Gastroenterology:
U.S. Rep. Renee Ellmers Tours Raligh Endoscopy Center
How Will Bundled Payments Affect GI? 3 Gastroenterologists Chime In
Colorectal Cancer Screening Cost-Effective for Older Adults: 6 Things to Know
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- UnitedHealthcare now posts Healthgrades star ratings for each physician: 7 key notes
- Joint Commission: New tools for medical error prevention
- Mederi Therapeutics launches 3rd generation of Stretta, Boston Scientific reports Q1 2016 financials & more — 5 GI company key notes
- Gastroenterologist pay in the US, UK, Canada & Australia: 5 notes
- Seres Therapeutics signs research agreements to support development of microbiome therapy for IBD: 3 points